JP2024511997A5 - - Google Patents
Info
- Publication number
- JP2024511997A5 JP2024511997A5 JP2023557288A JP2023557288A JP2024511997A5 JP 2024511997 A5 JP2024511997 A5 JP 2024511997A5 JP 2023557288 A JP2023557288 A JP 2023557288A JP 2023557288 A JP2023557288 A JP 2023557288A JP 2024511997 A5 JP2024511997 A5 JP 2024511997A5
- Authority
- JP
- Japan
- Prior art keywords
- depression
- disorder
- dystonia
- disease
- disorders
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163163470P | 2021-03-19 | 2021-03-19 | |
| US63/163,470 | 2021-03-19 | ||
| PCT/US2022/021057 WO2022198114A1 (en) | 2021-03-19 | 2022-03-20 | Prodrugs of kv7 channel openers |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024511997A JP2024511997A (ja) | 2024-03-18 |
| JP2024511997A5 true JP2024511997A5 (OSRAM) | 2025-03-17 |
Family
ID=83321210
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023557407A Pending JP2024511057A (ja) | 2021-03-19 | 2022-03-20 | Ｋｖ７チャネル開口剤のプロドラッグ |
| JP2023557288A Pending JP2024511997A (ja) | 2021-03-19 | 2022-03-20 | Ｋｖ７チャネル開口剤のプロドラッグ |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023557407A Pending JP2024511057A (ja) | 2021-03-19 | 2022-03-20 | Ｋｖ７チャネル開口剤のプロドラッグ |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US20240300894A1 (OSRAM) |
| EP (3) | EP4308544A4 (OSRAM) |
| JP (2) | JP2024511057A (OSRAM) |
| KR (2) | KR20230159506A (OSRAM) |
| CN (3) | CN117295711A (OSRAM) |
| AU (3) | AU2022237675A1 (OSRAM) |
| BR (2) | BR112023019074A2 (OSRAM) |
| CA (3) | CA3214084A1 (OSRAM) |
| IL (2) | IL306005A (OSRAM) |
| MX (2) | MX2023010978A (OSRAM) |
| WO (3) | WO2022198116A1 (OSRAM) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115364229B (zh) * | 2022-09-26 | 2024-02-20 | 江苏海洋大学 | 一种用于预防或治疗疼痛的药物组合物 |
| CN118553447B (zh) * | 2024-07-30 | 2024-11-08 | 四川大学华西医院 | 动态惊恐障碍治疗方案推荐系统、治疗系统及存储介质 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4200259A1 (de) * | 1992-01-08 | 1993-07-15 | Asta Medica Ag | Neue 1,2,4-triaminobenzol-derivate und verfahren zu deren herstellung |
| JP2004115450A (ja) * | 2002-09-27 | 2004-04-15 | Tanabe Seiyaku Co Ltd | 医薬組成物 |
| US20060004197A1 (en) * | 2004-07-02 | 2006-01-05 | Thomas Thrash | Sulfonamide-based compounds as protein tyrosine kinase inhibitors |
| US20090118285A1 (en) * | 2006-02-07 | 2009-05-07 | H. Lundbeck A/S | Use of kcnq-openers for treating or reducing the symptoms of schizophrenia |
| AU2009270768A1 (en) * | 2008-07-18 | 2010-01-21 | Valeant Pharmaceuticals International | Modified release formulation and methods of use |
| GB0813403D0 (en) * | 2008-07-22 | 2008-08-27 | Lectus Therapeutics Ltd | Potassium ion channel modulators & uses thereof |
| CN103073455B (zh) * | 2011-10-25 | 2015-08-19 | 中国科学院上海药物研究所 | 一类新型的kcnq钾通道激动剂、其制备方法和用途 |
| WO2013179298A2 (en) * | 2012-04-23 | 2013-12-05 | Cadila Healthcare Limited | A process for preparation of phenyl carbamate derivative and polymorphic forms thereof |
| US10526280B2 (en) * | 2014-11-13 | 2020-01-07 | University of Pittsburgh—of the Commonwealth System of Higher Education | (2-amino-4-(arylamino)phenyl carbamates |
| MX2018015251A (es) * | 2016-06-10 | 2019-04-25 | Scifluor Life Sciences Inc | Derivados de 2-amino-4-(amino sustituido)fenil carbamato fluorinado. |
| WO2020047603A1 (en) * | 2018-09-06 | 2020-03-12 | Monash University | Method of treating a sleep breathing disorder |
-
2022
- 2022-03-20 US US18/282,934 patent/US20240300894A1/en active Pending
- 2022-03-20 IL IL306005A patent/IL306005A/en unknown
- 2022-03-20 WO PCT/US2022/021059 patent/WO2022198116A1/en not_active Ceased
- 2022-03-20 EP EP22772332.7A patent/EP4308544A4/en active Pending
- 2022-03-20 CA CA3214084A patent/CA3214084A1/en active Pending
- 2022-03-20 MX MX2023010978A patent/MX2023010978A/es unknown
- 2022-03-20 CA CA3214270A patent/CA3214270A1/en active Pending
- 2022-03-20 IL IL306004A patent/IL306004A/en unknown
- 2022-03-20 EP EP22772331.9A patent/EP4308543A4/en active Pending
- 2022-03-20 WO PCT/US2022/021058 patent/WO2022198115A1/en not_active Ceased
- 2022-03-20 JP JP2023557407A patent/JP2024511057A/ja active Pending
- 2022-03-20 AU AU2022237675A patent/AU2022237675A1/en active Pending
- 2022-03-20 MX MX2023010976A patent/MX2023010976A/es unknown
- 2022-03-20 JP JP2023557288A patent/JP2024511997A/ja active Pending
- 2022-03-20 CN CN202280034079.2A patent/CN117295711A/zh active Pending
- 2022-03-20 AU AU2022240779A patent/AU2022240779A1/en active Pending
- 2022-03-20 CN CN202280034756.0A patent/CN117321031A/zh active Pending
- 2022-03-20 CA CA3214305A patent/CA3214305A1/en active Pending
- 2022-03-20 BR BR112023019074A patent/BR112023019074A2/pt unknown
- 2022-03-20 BR BR112023019077A patent/BR112023019077A2/pt unknown
- 2022-03-20 KR KR1020237035629A patent/KR20230159506A/ko active Pending
- 2022-03-20 CN CN202280034761.1A patent/CN117355503A/zh active Pending
- 2022-03-20 WO PCT/US2022/021057 patent/WO2022198114A1/en not_active Ceased
- 2022-03-20 AU AU2022239618A patent/AU2022239618A1/en active Pending
- 2022-03-20 EP EP22772333.5A patent/EP4308545A4/en active Pending
- 2022-03-20 KR KR1020237035814A patent/KR20230159531A/ko active Pending
- 2022-03-20 US US18/282,940 patent/US20240228434A1/en active Pending
- 2022-03-20 US US18/282,943 patent/US20240208896A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7390449B2 (ja) | 医学的障害の治療のためのアリール、ヘテロアリール及び複素環式医薬化合物 | |
| CN101528214B (zh) | 取代的n-酰基苯胺及其使用方法 | |
| JP2025504859A5 (OSRAM) | ||
| JP2012503009A5 (OSRAM) | ||
| TW201720438A (zh) | 用於治療醫學病症之化合物 | |
| JP2020519661A5 (OSRAM) | ||
| JP2023052297A (ja) | 医学的障害の治療のためのアリール、ヘテロアリール及び複素環式化合物 | |
| JP2019520416A5 (OSRAM) | ||
| JP7635138B2 (ja) | 補体媒介性障害の治療のための医薬化合物 | |
| JP2010531879A5 (OSRAM) | ||
| JP2018505898A5 (OSRAM) | ||
| TW201718551A (zh) | 用於治療醫學病症之醯胺化合物 | |
| JP2015512951A5 (OSRAM) | ||
| TW201718611A (zh) | 用於治療醫學病症之膦酸酯化合物 | |
| JP2018514544A5 (OSRAM) | ||
| JP2008520589A5 (OSRAM) | ||
| JP2024511057A5 (OSRAM) | ||
| TW201716370A (zh) | 作為化療劑的β－取代的β－氨基酸和類似物及其應用 | |
| JP2013531006A5 (OSRAM) | ||
| JP2019534327A5 (OSRAM) | ||
| JP7794910B2 (ja) | Ｅａａｔ２活性化因子およびその使用方法 | |
| JP2019529460A5 (OSRAM) | ||
| EP3846803A2 (en) | Macrocyclic compounds for the treatment of medical disorders | |
| JP2015500223A5 (OSRAM) | ||
| JP2014532730A5 (ja) | オピオイド受容体の調節物質およびそれを含む薬学的組成物 |